Srivichai Vejvivat Public Company Limited (“the Company” or VIH) was established in 1993 to operate a private hospital business under the name of Vichaivej International Hospital Om Noi, which is a hospital under the Vichaivej International Hospital Group. The Company had a registered capital of 200 million baht at the time of its establishment in 1993. The major shareholders and directors with control are Assoc. Prof. Dr. Vichai Vandurongwan and Asst. Prof. Dr. Saisunee Vandurongwan, the founders of the hospital group.
In 2008, the Company underwent a restructuring by acquiring ordinary shares of Saivichai Development Co., Ltd. and Srisakhon Vejavivat Co., Ltd. from the directors who were the former shareholders in order to restructure the investment of the group of companies to be in line with the business direction in the form of a hospital group, with Saivichai Development Co., Ltd. and Srisakhon Vejavivat Co., Ltd. as subsidiaries.
In 2012, the Company was listed on the Stock Exchange of Thailand (SET) with a total registered capital of 535 million baht, divided into 535 million ordinary shares with a par value of 1 baht per share, with a paid-up capital of 535 million baht. In 2017, the Company increased its registered capital by 35,666,666 baht from the original registered capital of 535,000,000 baht to a new registered capital of 570,666,666 baht by issuing 35,666,666 newly issued ordinary shares with a par value of 1.00 baht per share, resulting in a paid-up capital of 570,665,433 baht.
In 2014, BBTV Equity Co., Ltd. acquired 20% of the total shares in the Company, resulting in a change in the Company's major shareholder group to support the expansion of the hospital and medical service businesses to be more comprehensive in the future.
In 2016, the Company acquired 89,998 ordinary shares of Bangkok Orthopedic Hospital Co., Ltd., representing 99.99% of the registered capital from the existing shareholders of Samyaek Faisai Polyclinic Co., Ltd., for a total value of 155,000,000 baht, according to the resolution of the 2016 Annual General Meeting of Shareholders on June 28, 2016.
In 2024, on Friday, April 26, 2024, the Company resolved to increase the registered capital of the Company by 57,066,546 baht from the original registered capital of 570,665,433 baht to a registered capital of 627,731,979 baht by issuing no more than 57,066,546 newly issued ordinary shares with a par value of 1.00 baht per share to support the allocation of newly issued ordinary shares to be offered to existing shareholders in proportion to their shareholding (Right Offering) of no more than 38,044,364 shares and to support the exercise of warrants to purchase ordinary shares of the Company No. 1 (VIH-W1) to be issued and allocated to existing shareholders who subscribe for and are allocated newly issued ordinary shares of no more than 19,022,182 shares.
In addition, in 2024, the Company invested in a new hospital project with a total value of not more than 2,735.01 million baht to enhance its competitiveness in elevating the quality of service to excellence in tertiary medical care. A new subsidiary was established under the name of "Watthana Vejvivat Co., Ltd.", in which registered capital 1,241 million baht , representing 100% of the registered capital
Vichaivej Hospital Group operates general hospitals at the secondary level and has 4 hospitals in the group: 1) Vichaivej International Hospital Om Noi, 2) Vichaivej International Hospital Nong Khaem, 3) Vichaivej International Hospital Samutsakhon, and 4) Vichaivej Hospital Yaek Fai Chai, which are operated by the Company and its subsidiaries, namely Srivichai Vejvivat Public Company Limited, Saivichai Development Co., Ltd. (subsidiary), Srisakhon Vejavivat Co., Ltd. (subsidiary), and Bangkok Orthopedic Hospital Co., Ltd. (subsidiary), respectively. In addition, the Company also has another subsidiary, Srivichai Vocational School Co., Ltd., which operates under the name of Srivichai Vocational School to produce caregivers for the elderly and young children. The Company and its subsidiaries operate under the management of Asst. Prof. Dr. Saisunee Vandurongwan, who has held the position of Chief Executive Officer and Vice Chairman of the Board of Directors since its inception.